BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells
about
Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cellsEmerging therapies for severe asthma11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excessGlucocorticoid receptor binds half sites as a monomer and regulates specific target genesConstitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways.A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using LuminexInflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival CellsTissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.The nature of the GRE influences the screening for GR-activity enhancing modulators.Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1).Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.The transrepression arm of glucocorticoid receptor signaling is protective in mutant huntingtin-mediated neurodegeneration.Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cellsUnique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X.
P2860
Q24619895-C7C8C346-8543-4323-9D34-C7A09E065BE8Q26861260-6B0BC158-9078-48FC-8C3F-BE063D6BFCB2Q33789944-13A87958-EA22-4CDF-9EBF-84B11B95CA05Q34109185-C27C24E9-DF7A-4CE9-BA2D-BAC96DD6A647Q34166698-33579580-0D6A-47F3-95FC-B35D09477140Q34912766-1E2313E9-D729-42C3-92FE-6BC743950BD9Q36074078-D9ADB576-19B4-4B5B-88EB-B9CDDF4CE192Q37679245-ED264308-175B-4956-9AC8-327061BCDD4CQ38697860-92A86D45-D431-4866-8F47-78449312EA45Q39296353-C0FBCF3C-66DD-4320-93C7-58DFA43B5E8DQ39423430-80E94B0A-6A68-41FD-85D5-E46BFA3822C9Q39515328-23BBF839-95DD-48C2-AF14-F0BE445D4155Q40816092-B82B3814-4607-4443-B6CF-748A8B84FAAFQ41244698-C7313F3A-3869-439A-9CB0-805634DCF4F2Q42743183-7CB810BD-870E-42A4-9FCD-34CA687EA13BQ43225993-017FA17B-ED39-411D-A504-66985F56A2A8
P2860
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@ast
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@en
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@nl
type
label
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@ast
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@en
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@nl
prefLabel
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@ast
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@en
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@nl
P2093
P2860
P921
P1433
P1476
BOL-303242-X, a novel selectiv ...... operties in human ocular cells
@en
P2093
Francisco J López
Jin-Zhong Zhang
Karl R VanderMeid
Keith W Ward
Megan E Cavet
Mercedes Salvador-Silva
P2860
P304
P407
P577
2009-01-01T00:00:00Z